EPIC-Norfolk Publications Database

Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.

Campa D, Hüsing A, Dostal L, Stein A, Drogan D, Boeing H, Tjønneland A, Roswall N, Østergaard JN, Overvad K, Rodriguez L, Bonet C, Sánchez MJ, Larrañaga N, Huerta JM, Ardanaz E, Khaw KT, Wareham N, Travis RC, Allen NE, Trichopoulou A, Zylis D, Karapetyan T, Palli D, Sieri S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Lenner P, Johansson M, Jenab M, Cox D, Siddiq A, Kaaks R, and Canzian F

Oncology reports. Mar 2011

(DOI : 10.3892/or.2011.1359)

Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC).

Campa D, Claus R, Dostal L, Stein A, Chang-Claude J, Meidtner K, Boeing H, Olsen A, Tjønneland A, Overvad K, Rodriguez L, Bonet C, Sánchez MJ, Amiano P, Huerta JM, Barricarte A, Khaw KT, Wareham NJ, Travis RC, Allen NE, Trichopoulou A, Bamia C, Benetou V, Palli D, Agnoli C, Panico S, Tumino R, Sacerdote C, van Kranen H, Bas Bueno-de-Mesquita H, Peeters PH, van Gils CH, Lenner P, Sund M, Lund E, Gram IT, Rinaldi S, Chajès V, Romieu I, Engel P, Boutron-Ruault MC, Clavel-Chapelon F, Siddiq A, Riboli E, Canzian F, and Kaaks R

Breast cancer research and treatment. Oct 2010

(DOI : 10.1007/s10549-010-1269-1)

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).

Campa D, Hüsing A, Stein A, Dostal L, Boeing H, Pischon T, Tjønneland A, Roswall N, Overvad K, Østergaard JN, Rodriguez L, Sala N, Sánchez MJ, Larrañaga N, Huerta JM, Barricarte A, Khaw KT, Wareham NJ, Travis RC, Allen NE, Lagiou P, Trichopoulou A, Trichopoulos D, Palli D, Sieri S, Tumino R, Sacerdote C, van Kranen H, Bueno-de-Mesquita HB, Hallmans G, Johansson M, Romieu I, Jenab M, Cox DG, Siddiq A, Riboli E, Canzian F, and Kaaks R

PLoS ONE. Oct 2010

(DOI : 10.1371/journal.pone.0016914)

Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).

Campa D, Hüsing A, Chang-Claude J, Dostal L, Boeing H, Kröger J, Tjønneland A, Roswall N, Overvad K, Dahm CC, Rodriguez L, Sala N, Pérez MJ, Larrañaga N, Chirlaque MD, Ardanaz E, Khaw KT, Wareham NJ, Allen NE, Travis RC, Trichopoulou A, Naska A, Bamia C, Palli D, Sieri S, Tumino R, Sacerdote C, van Kranen HJ, Bas Bueno-de-Mesquita H, Stattin P, Johansson M, Chajès V, Rinaldi S, Romieu I, Siddiq A, Norat T, Riboli E, Kaaks R, and Canzian F

European journal of cancer (Oxford, England : 1990). Apr 2010

(DOI : 10.1016/j.ejca.2010.09.029)